Targeting properties of peptide-modified radiolabeled liposomal nanoparticles

Abstract Radiolabeled PEGylated liposomal nanoparticles (NPs) open new possibilities for a variety of applications including diagnosis, drug delivery, targeted therapy, and monitoring treatment effects. Here we describe the characterization of liposomal NPs (liposomes and micelles) derivatized with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nanomedicine 2012, Vol.8 (1), p.112-118
Hauptverfasser: Helbok, Anna, MSc, Rangger, Christine, MSc, von Guggenberg, Elisabeth, PhD, Saba-Lepek, Matthias, PhD, Radolf, Thorsten, Ing, Thurner, Gudrun, MSc, Andreae, Fritz, PhD, Prassl, Ruth, PhD, Decristoforo, Clemens, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Radiolabeled PEGylated liposomal nanoparticles (NPs) open new possibilities for a variety of applications including diagnosis, drug delivery, targeted therapy, and monitoring treatment effects. Here we describe the characterization of liposomal NPs (liposomes and micelles) derivatized with the somatostatin analogue tyrosine-3-octreotide as a proof of concept for tumor targeting. NPs were radiolabeled with indium-111, and targeting properties were evaluated in vitro on rat pancreatic tumor cells (AR42J), demonstrating specific binding and IC50 values in the low nanomolar range. Biodistribution studies were performed in Lewis rats and compared to single-photon emission computed tomography images. Moderate tumor uptake was found in xenografted nude mice (
ISSN:1549-9634
1549-9642
DOI:10.1016/j.nano.2011.04.012